Anúncio
Anúncio

Mais conteúdo relacionado

Similar a Most Commonly Used Stock Pitch Deck PowerPoint Presentation PPT Slide Template(20)

Anúncio

Mais de SlideTeam(20)

Anúncio

Most Commonly Used Stock Pitch Deck PowerPoint Presentation PPT Slide Template

  1. Most Commonly Used Stock Pitch Deck
  2. Company Introduction 2 Catalyst Risk › Leading market position of Hepatitis B treatments- Product A & Product B › Clinical trials on newer, better drugs including Product C & Product D › Recently announced $0.51/share dividend reveals strong cash position and management confidence in their business › Uncertainty regarding Product A pricing and Product B patent status in light of competition and litigation with Competitor A › Pipeline drugs may face rejection from board › Expiring patents require improvement and approval of new drugs to withstand growth in revenue Recommendation: Buy Target Price: $145.09 (32% growth) We are market leaders in hepatitis B and cancer treatment, strong cash inflows and strong sales pipeline to craft a compelling investment that is highly undervalued in market. AboutUs: Current Price: $109.78 This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
  3. Industry Outlook 3 7% 17% 11% 23% 42% Market Share Company A Company B Company C Company D Others 2 Sub-industries: Medical, Agricultural › High Entry Barriers o Due to huge initial investment o Risk of extra time consumption › Demand curve- Vertical › Change in business model o Recession - Lack of PE funding ✓ Pharmaceutical partners ✓ Internal sources o Vertical integration- Increased profit margins › Tight government regulation o Increased cost for companies Industry Trends This graph/chart is linked to excel, and changes automatically based on data. Just left click on it and select “Edit Data”.
  4. Future Industry Growth 4 0 20 40 60 80 100 120 140 160 Millions Annual Growth 16' -19' 19' -23' 0 4 8 12 16 20 Exports Imports Millions 16' -19' 19' -23' Total Tax Cost = $71-$83 Million Biologics Price Competition & Innovation Act Mandate = $110 Million Profit = $15 -$25 Million This graph/chart is linked to excel, and changes automatically based on data. Just left click on it and select “Edit Data”. Increased Focus on Emerging Markets Diversify Product Segment Focus on Baby Boomers, Since they form a big share of our customers
  5. Company Overview (Template 1/2) 5 Year of establishment – 1990 Employee strength – 10,000 Catered industries – Healthcare, Insurance, Telecommunications, Utilities Geographic presence – Different states of USA Client base – More than 12,000 clients worldwide (Banks, Financial companies and retailers, etc.) Headquarters – Wisconsin, United States Product categorization – Payments, Processing services, Risk & Compliance, Customer & Channel Management Revenue - $1 Billion for Year ended 30 December 2018 This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
  6. Company Overview (Template 2/2) 6 Background › Add details on company’s history › Previous line of services › How it all started etc. › Other key points Capabilities › Key services offered/Production capacity › Milestones achieved in services offered/production › Key projects handled Accreditation › List of main accreditation, if any Company’s Vision › This slide is 100% editable. Adapt it to your needs and capture your audience's attention. Company’s Mission › This slide is 100% editable. Adapt it to your needs and capture your audience's attention. Promoters and Shareholding 2,022 3,184 3,476 4,621 6,168 19% 22% 23% 17% 19% 2% 9% 10% 5% 7% 0% 5% 10% 15% 20% 25% 30% 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 FY15 FY16 FY17 FY18 FY19 USDMillion Financial Highlights Revenue Operating Profit Margin Profit Margin CAGR R: 32% E: 30% NI: 83% This graph/chart is linked to excel, and changes automatically based on data. Just left click on it and select “Edit Data”. One liner on CMD’s background : One liner on CEO’s background One liner of company’s key shareholder; e.g. PE investor
  7. Past Acquisitions 7 Year Company Price Importance 2006 Company 1 $245 Million Respiratory Arena; Cystic Fibrosis 2006 Company 2 $2.5 billion Pulmonary Diseases 2009 Company 3 $1.7 billion Cardiovascular Franchise 2010 Company 4 $225 Million Fibrotic Diseases; Cancer 2011 Company 5 $17.2 billion Hepatitis C 2015 Company 6 $470 Million Liver Diseases This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
  8. Senior Software Architect Deforest Kelley Add education here Roles & Responsibilities and project undertaken › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here Senior Quality Assurance Engineer William Shatner Add education here Roles & Responsibilities and project undertaken › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here Our Team (1/2) 8This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
  9. › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here › Text Here Nichelle Nichols Technical Lead Add education here Leonard Nimoy Project Manager Add education here Matt Kapers Project Lead Add education here Our Team (2/2) 9This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
  10. Organizational Structure (Option 1 of 2) 10 Text Here Text Here Text Here Text Here Text Here Text Here Text Here Text HereText Here Text Here Text Here Text Here Text Here This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
  11. John Smith CEO Jenny Clark Product Manager Elisabeth Parker Product Manager Marry Sweet Product Manager Julie Hill Web Designer Even Turner Marketing Ali Taylor Graphic Designer Mark Hall Marketing John Wood Graphic Designer Steven Walker Web Designer Anita Brown Marketing Peter Tucker Web Designer Jasmin Carter Graphic Designer Organizational Structure (Option 2 of 2) 11This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
  12. Art Director ANITA SMITH Text Here Text Here Text Here Text Here Personal Skills This slide is 100% editable. Adapt it to your needs and capture your audience's attention. Your Text Here This slide is 100% editable. Adapt it to your needs and capture your audience's attention. Your Text Here This slide is 100% editable. Adapt it to your needs and capture your audience's attention. Your Text Here Member Profile 12
  13. Geographical Reach 13 Year Founded 2016 2016 Revenue $7.3 Billion Approximately 560,000 Products Number of Employees Approximately 9,300 Over 50 countries Approximately 200,000 customers Over 360 Clies Fortune 600 List Stock Symbol AXE This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
  14. Our Services (Option 1 of 2) 14 What We Do? Graphic Design services Web Design services Web Development services This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
  15. This slide is 100% editable. Adapt it to your needs and capture your audience's attention. This slide is 100% editable. Adapt it to your needs and capture your audience's attention. This slide is 100% editable. Adapt it to your needs and capture your audience's attention. This slide is 100% editable. Adapt it to your needs and capture your audience's attention. Digital Advertising Marketing & Analytics Digital Care Package Security & Maintenance Our Services (Option 2 of 2) 15This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
  16. Mobile App Showcase 16This slide is 100% editable. Adapt it to your needs and capture your audience's attention. GPS Ability › Your Text here › Your Text here › Your Text here Fast & Furious › Your Text here › Your Text here › Your Text here Clean Coding › Your Text here › Your Text here › Your Text here Mobile Apps › Your Text here › Your Text here › Your Text here Users friendly › Your Text here › Your Text here › Your Text here E- Commerce Ability › Your Text here › Your Text here › Your Text here
  17. Projects in Pipeline 17 › 10 new drugs in the pipeline: 1 in NDA, 2 in phase 3, 4 in phase 2, and 3 in phase 1 › Shifting focus to oncology products, market with more than $10B in sales last year › Notable products: › Product 1 › Product 2 › Product 3 › Add text here › Add Text here › Add text here Overview › General Applications › Oncology and non-oncology applications: NASH, IPF, liver fibrosis › Add text here › Add text here Project Description by Product
  18. Risk & Mitigation 18 Risk Mitigation Commercial Competition in the cancer and HIV franchise Legal Pending litigation with name 1 over patent A; uncertainty regarding intellectual property rights to combination therapies Developmental Drugs may fail to prove efficacy in clinical trials Regulatory Company may fail to secure regulatory approval on new products Drug from Competitor A is inferior in many fields based on clinical data Will most likely obtain patent Given the company’s past achievements, new drugs are likely to be efficacious as well. Will most likely obtain regulatory approval
  19. Company Valuation Analysis 19 Company Share Price (US$) Market Value (US$) Enterprise Value (US$MM) Revenue Growth % Current P/E NTM P/E EV/ EBITDA EV/ EBIT PEG Ratio Company 1 153.48 116,747.60 120,436.60 7.4% 16.5 16.2 12.0 13.3 1.57 Company 2 115.88 92,553.80 92,530.40 18.1% 24.0 23.2 18.1 18.3 0.90 Company 3 182.29 36,849.70 30,052.70 92.2% 30.8 29.9 25.8 26.3 1.20 Company 4 402.40 41,293.10 40,390.10 34.0% 37.7 37.0 30.1 35.1 2.07 Company 5 391.66 91,889.10 89,163.00 87.9% 23.0 22.6 15.8 16.4 1.29 Mean 249.14 75,866.66 75,514.56 47.92% 26.4 25.78 20.36 21.88 1.41 Median 182.29 91,889.10 89,163.00 34.00% 24.0 23.2 18.1 18.3 1.29 High 402.40 116,747.60 120,436.60 92.20% 37.7 37.0 30.1 35.1 2.07 Low 115.88 36,849.70 35,052.70 7.20% 16.5 16.2 12.0 13.3 0.90 Our Company 101.90 153,732.90 155,748.70 122.20% 10.7 10.6 8.8 8.7 0.46 This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
  20. DCF -valuation 2014A Enterprise value (“EV”) 11,012 Equity value (“market cap”) 10,812 Price per share 1,08 Implied multiplies 2017A 2018E 2019E 2020E 2021E Sales 2,4x 2,2x 2,0x 1,9x 1,8x EBITDA 9,7x 8,7x 8,1x 7,6x 7,2x EBIT 10,5x 9,3x 8,7x 8,1x 7,7x Discounted Cash Flow Analysis 20 Actual Forecast period CAGR CAGR 2014A 2015A 2016A 2017A 2018E 2019E 2020E 2021E 2022E 2014-2017A 2018-2022E Net Sales 2,955 3,568 4,102 4,663 5,036 5,388 5,711 5,997 6,237 16.4% 5.5% Growth, % 20,7% 15,0% 13,7% 8,0% 7,0% 6,0% 5.0% 4,0% COGS -2,098 -2,516 -2,831 -3,310 -3,544 -3,792 -4,019 -4,220 -4,389 16.4% 5.5% Gross Profit 857 1,053 1,272 1,352 1,492 1,596 1,692 1,777 1,848 16.4% 5.5% Margin, % 29,0% 29,5% 31,0% 29,0% 29,6% 29,6% 29,6% 29,6% 29,6% OPEX -180 -200 -210 -215 -224 -232 -240 -249 -257 6.1% 3.5% Growth, % 11,1% 5,0% 2,4% 4,0% 3,8% 3,6% 3,4% 3,3% In % of net sales 6,1% 5,6% 5,1% 4,6% 4,4% 4,3% 4,2% 4,1% 4,1% EBITDA 677 853 1,062 1,137 1,268 1,364 1,452 1,528 1,591 18.9% 5.8% Margin, % 22,9% 23,9% 25,9% 24,4% 25,2% 25,3% 25,4% 25,5% 25,5% Depreciation -49 -63 -75 -84 -88 -95 -100 -105 -110 19.8% 5.5% In % of net sales 1,6% 1,8% 1,8% 1,8% 1,8% 1,8% 1,8% 1,8% 1,8% EBIT 628 790 987 1,053 1,180 1,270 1,351 1,423 1,481 18.8% 5.9% Tax (30%) -119 -138 -151 -164 -354 -381 -405 -427 -444 11.4% 5.9% Capex -79 -41 -169 -115 -123 -130 -136 -142 n.a. 0 In % of net sales 2,2% 1,0% 3,6% 2,3% 2,3% 2,3% 2,3% 2,3% Increase/Decrease in NWC -25 -5 -2 -15 -14 -13 -11 -9 Unlevered free cash flow 611 865 802 785 847 904 954 995 This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
  21. Base Case: $114.76 (12% Upside) › Revenue estimates based on Bloomberg consensus; 5% revenue CAGR through 2019 › 80% gross margin; in line with historical › 9x exit multiple, implying 3% perpetual growth Bull Case: $135.7 (27% upside) › Revenue Estimates Based On Bloomberg Consensus; 4% Revenue CAGR Through 2019 › 91% Gross Margin; Slight Improvement From Historical, Consistent With Analyst Consensus › 12x Exit Multiple, Implying 3.6% Perpetual Growth Bear Case: $88.7 (10% downside) › Revenue Flat in 2017 Followed by 3% CAGR Through 2019 › 85% Gross Margin; in Line with Historical › 10x Exit Multiple, Implying 1.8% Perpetual Growth Price Target 21This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
  22. 22 Additional Slides
  23. Combo Chart 23 Profit(InPercentage) 0 10 20 30 40 50 60 70 80 90 100 2016 2017 2018 2019 Product 01 Product 02 Product 03 This graph/chart is linked to excel, and changes automatically based on data. Just left click on it and select “Edit Data”.
  24. 24 OurMission Goal This slide is 100% editable. Adapt it to your needs and capture your audience’s attention. Vision This slide is 100% editable. Adapt it to your needs and capture your audience’s attention. Mission This slide is 100% editable. Adapt it to your needs and capture your audience’s attention.
  25. 2015 2016 2019 2018 2017 Timeline 25 2014 This slide is 100% editable. Adapt it to your needs and capture your audience’s attention. This slide is 100% editable. Adapt it to your needs and capture your audience’s attention. This slide is 100% editable. Adapt it to your needs and capture your audience’s attention. This slide is 100% editable. Adapt it to your needs and capture your audience’s attention. This slide is 100% editable. Adapt it to your needs and capture your audience’s attention. This slide is 100% editable. Adapt it to your needs and capture your audience’s attention.
  26. Our Target 26 This slide is 100% editable. Adapt it to your needs and capture your audience’s attention. This slide is 100% editable. Adapt it to your needs and capture your audience’s attention. This slide is 100% editable. Adapt it to your needs and capture your audience’s attention. Target 01 This slide is 100% editable. Adapt it to your needs and capture your audience’s attention. Target 02 This slide is 100% editable. Adapt it to your needs and capture your audience’s attention. Target 03 This slide is 100% editable. Adapt it to your needs and capture your audience’s attention.
  27. 27 I choose a lazy person to do a hard job. Because a lazy person will find an easy way to do it. - Bill Gates Quotes
  28. 28 ThankYou Address # street number, city, state Email Address emailaddress123@gmail.com Contact Number 0123456789
Anúncio